{"id":"W4416019029","doi":"10.1016/j.ijgc.2025.102231","title":"PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 ENGOT-CX12/GOG-3057/INNOVATV 301 TRIAL OF TISOTUMAB VEDOTIN AS SECOND/THIRD-LINE TREATMENT FOR RECURRENT OR METASTATIC CERVICAL CANCER","year":2025,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cervical cancer; Phases of clinical research; Clinical trial; MEDLINE; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002491199,0.0007149063,0.001454228,0.0002970259,0.0003087714,0.0009721807,0.0005692046,0.001024025,0.004580765],"category_scores_gemma":[0.002971954,0.0002040824,0.003645046,0.0004709483,0.0003698272,0.0008809672,0.0004398955,0.002750671,0.0006792157],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007379773,"about_ca_system_score_gemma":0.0005414545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001527077,"about_ca_topic_score_gemma":0.004423222,"domain_scores_codex":[0.9989642,0.0004447445,0.00008718223,0.0001577674,0.0001628785,0.0001831669],"domain_scores_gemma":[0.9980375,0.0006611869,0.0006401938,0.0001037858,0.0001986146,0.0003587283],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6774551,0.004409833,0.09240898,0.006180912,0.04121711,0.0003320932,0.0002849633,0.008220128,0.004168872,0.0008347311,0.0277167,0.1367706],"study_design_scores_gemma":[0.259451,0.1212153,0.5365881,0.001158157,0.04346277,0.001376322,0.0005391406,0.00615543,0.002351307,0.002520723,0.0248847,0.0002970877],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9434791,0.02312974,0.0005669859,0.001524121,0.0003495138,0.0005269876,0.02312155,0.00007621254,0.007225757],"genre_scores_gemma":[0.9755206,0.003477284,0.0003937877,0.001142821,0.000208008,0.0003908135,0.01624671,0.00002394851,0.002596124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004580765,"threshold_uncertainty_score":0.01532418,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09977714570942955,"score_gpt":0.4371736659598395,"score_spread":0.33739652025041,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}